Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Edgewater › NPI 1750468971

Leykin, Tanya

Leykin, Tanya was paid $2.05M by Medicaid between Jan 2018 and Nov 2024, across 41 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.

33Billing provider infoLEYKIN, TANYA
EDGEWATER, NJ 07020
33aNPI1750468971assigned 11/01/2006
33bProvider typeLegal Medicine
28Total paid$2.05M
24GClaims65,382
24DCodes billed41
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Legal Medicine providers in New Jersey

Rank by total paid#2 of 15
Median peer was paid$168K
This provider vs. median12×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20189,794$359K
201910,511$355K
20207,785$237K
20219,079$281K
202211,358$327K
20239,882$288K
2024incomplete6,973$199K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 37% 17,110 13,990 $759K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 20% 6,742 5,612 $411K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 10% 6,550 5,773 $213K
90460 Immunization administration through 18 years of age via any route, first or only component 4.8% 6,439 6,334 $99K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4.6% 1,698 1,692 $95K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 3.5% 1,326 1,324 $73K
96110 Developmental screening, with scoring and documentation, per standardized instrument 3.3% 3,807 3,719 $67K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 2.6% 1,834 1,344 $54K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2.3% 867 843 $47K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2.3% 796 789 $46K
92551 1.6% 3,307 3,280 $33K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.4% 2,801 2,316 $29K
29 more codes
94664 1.2% 2,725 $24K
90461 1.0% 1,346 $21K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,319 $18K
99401 <1% 735 $13K
90656 <1% 1,506 $10K
90677 <1% 35 $7K
86580 <1% 736 $3K
90671 <1% 18 $3K
90651 <1% 68 $3K
99173 <1% 1,491 $3K
99204 Doctor's office visit, new patient (more involved) <1% 27 $3K
99215 Doctor's office visit, returning patient (complex) <1% 33 $3K
96127 <1% 658 $2K
90716 <1% 107 $2K
90655 <1% 401 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 73 $736.99
90734 <1% 12 $702.18
90660 <1% 102 $697.62
90670 <1% 122 $427.68
90700 <1% 74 $263.28
90713 <1% 12 $226.55
90472 Immunization administration, each additional vaccine (list separately) <1% 27 $198.18
90633 <1% 76 $183.85
96160 <1% 108 $177.91
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable <1% 175 $147.66
90648 0% 39 $0.00
90707 0% 27 $0.00
90698 0% 41 $0.00
90723 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.